The Future of
Health and Wellness

WHAT ARE MSC EXOSOMES IN EVERYDAY LANGUAGE?

Tiny vesicles from stem cells that deliver mission-critical growth factors

Naturally boost the body’s repair and renewal processes

Cell-to-cell communication without live cells

EXOSOMES

For informational and professional use only. These products are not intended to diagnose, treat, cure, or prevent any disease. Individual outcomes may vary. All applications should be performed by qualified professionals within their scope of practice.

Gel Formula 30ML

TOPICAL EXOSOMES

Harness the unmatched potential of topical MSC

exosomes that store for up to 18 months at room

temperature. With 2.5 billion exosomes per pump,

the extraordinary potency may provide a flexible,

cutting-edge solution for promoting cellular

regeneration and rejuvenation for a wide range of

applications.

5ML Saline Vial

PURE EXOSOME VIALS

Pure, sterile saline MSC exosomes may provide the pinnacle of revitalization

and rejuvenation. Whether it be an IV infusion, nebulization, or local injection,

MSC exosomes promote youthful cellular function and regeneration deep into the body, unlocking unlimited potential.

If Properly registered as a 351(a) biological product in the United States, MSC exosomes can be legally injected for research and investigatory purposes.

These MSC exosomes are subject to the FDA’s rigorous oversight and adhere to the highest standards of safety, purity, and potency.

STORAGE

• Room Temperature: 24 hour room half life

• Regular Freezer (-20c): 6 weeks stable

• Cryo-Freezer (-80c): 18 months stable

• Vials can be refrozen up to 3 times

CERTIFICATE OF ANALYSIS (COA)

With every batch, we provide a Certificate of Analysis verifying the precise quantity contained with in your vial. A

CoA is a crucial document that ensures that the product has been tested and meets specific quality standards .

It verifies that the product is of the expected quality, free from contaminants, and meets the specifications

outlined in the document.

• SAFETY : It provides information about the absence of harmful substances or contaminants, helping to

ensure that the product is safe for its intended use or consumption.

• COMPLIANCE : A CoA includes information about regulatory compliance, confirming that the product

meets legal and regulatory requirements.

• CONSISTENCY: It helps ensure batch - to - batch consistency by confirming that each batch of the

product meets the same quality and purity standards.

• TRANSPARENCY : A CoA provides transparency to customers, regulators, and others take holders by

offering a detailed break down of the product’ s composition, test results, and compliance with industry

standards.

• PRODUCT VERIFICATION: It allows customer so regulatory authorities to verify the product's

authenticity and quality, reducing the risk of counterfeit or substandard products in the market.

F D A DRUG MASTER FILE

Submission of a Drug Master File demonstrates

the manufacturer ’ s commitment to regulatory

compliance and quality assurance. It ensures that

the FDA has access to the necessary information

to assess the safety and potency of the product,

as well as manufacturing practices and processes.

Stem cell-derived exosomes are not currently approved by the FDA for use in medical treatments. They are exclusively sold for research purposes in various areas, including:

•Arthritis

•Bone fusion & regeneration

•Burns/wounds

•Cartilage regeneration

•Cerebral palsy

•COVID-19 long-haulers

•Dementia

•Glaucoma

•Hair Loss

•Injured ligaments/tendons

•Multiple sclerosis

•Orthopedics

•Osteoarthritis

•Peripheral nerve damage

•Sexual dysfunction

•Skin regeneration

•Spinal cord injuries

•Stroke

•Tissue repair

•Traumatic brain injury

•Vaginal regeneration

It is crucial to be aware that these products are intended solely for investigative purposes and should not be used as treatments or therapies without proper FDA approval. Patients and healthcare providers should exercise caution and consult with regulatory authorities and experts before considering the use of stem cell-derived exosomes for any medical purposes.